Humacyte, Inc. (HUMA) Tops Q4 EPS by 9c

Humacyte, Inc. (NASDAQ: HUMA) reported Q4 EPS of ($0.16), $0.09 better than the analyst estimate of ($0.25).

For earnings history and earnings-related data on Humacyte, Inc. (HUMA) click here.

You May Also Be Interested In

• Beam Global reports Q2 2026 revenue above $8.5M, up 170% from Q1
• Antero Midstream Partners LP (AM) PT Raised to $24 at Goldman Sachs into earnings
• Barclays on Rivian (RIVN) into earnings: 'Autonomy remains show me'